Pharmaceutical Development and Scientific Skepticism
30 Questions
2 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What may be necessary when a proposed new medicine's mechanism is not covered by published regulatory guidance?

  • Conducting additional clinical trials
  • Working interactively with regulatory officials (correct)
  • Amending the manufacturing process
  • Submitting a new regulatory filing
  • What is critical in planning a development program?

  • Determining whether proposed studies will satisfy regulatory requirements (correct)
  • Determining the target market for the new medicine
  • Finalizing the label for the new medicine
  • Conducting clinical and nonclinical studies
  • What is crucial for approved medicines after regulatory approval?

  • Labeling and packaging
  • Prolonged clinical trials
  • Conducting post-marketing surveillance
  • Manufacturing according to high standards of purity and stability (correct)
  • Why may manufacturing be complex and expensive for some medicines?

    <p>Particularly for biological products (NBEs)</p> Signup and view all the answers

    What is essential for medicines developed for Alzheimer's disease?

    <p>Regulatory guidance on new medicines in this area</p> Signup and view all the answers

    When planning a development program, what should be determined?

    <p>Whether the proposed studies will satisfy regulatory requirements</p> Signup and view all the answers

    What is a common issue with drug development approaches?

    <p>Focusing too exclusively on obtaining evidence of drug efficacy</p> Signup and view all the answers

    What is the benefit of evaluating measures associated with drug mechanism/hypothesis?

    <p>It can open new avenues of research as well as close them</p> Signup and view all the answers

    What is the purpose of a 'check list' in drug development?

    <p>To optimize the translation of a drug candidate through the nonclinical and clinical stages</p> Signup and view all the answers

    Why is it essential to publish both positive and negative drug development studies and clinical trials?

    <p>So that investigators can learn from earlier failures and improve methods and practices</p> Signup and view all the answers

    What is the result of not publishing negative drug development studies and clinical trials?

    <p>The predictive value of preclinical models cannot be evaluated</p> Signup and view all the answers

    What is the goal of a successful drug discovery and development program?

    <p>To maximize the potential for success and translate discoveries into clinical practice benefits</p> Signup and view all the answers

    What is the main reason drug developers are skeptical of new scientific findings?

    <p>Because of the high investment required to pursue a new biological target</p> Signup and view all the answers

    What percentage of findings reported in reputable journals cannot be reproduced?

    <p>At least 90%</p> Signup and view all the answers

    What is the main concern for investigators proposing a new biological target?

    <p>That the findings may not be reproducible</p> Signup and view all the answers

    What is required for a biological target to be useful for drug development?

    <p>That it can be affected by molecules in a therapeutically useful way</p> Signup and view all the answers

    What properties must molecules have to be considered a medicine?

    <p>That they can act like a medicine when given to people</p> Signup and view all the answers

    Why do industry investigators attempt to replicate reported findings?

    <p>To ensure the findings are reliable</p> Signup and view all the answers

    What is the approximate percentage of compounds entering clinical development that eventually gets approved for marketing in the pharmaceutical industry?

    <p>8%</p> Signup and view all the answers

    What is the success rate of compounds that entered clinical development for AD between 2002 and 2012?

    <p>0.4%</p> Signup and view all the answers

    Why do companies continue to invest in AD therapeutics despite the high failure rate?

    <p>Because the unmet medical need is great and there are scientifically plausible targets</p> Signup and view all the answers

    What percentage of clinical trials for AD between 2002 and 2012 were supported by the pharmaceutical industry?

    <p>78%</p> Signup and view all the answers

    What type of drug is memantine, which is approved for AD?

    <p>Symptomatic drug</p> Signup and view all the answers

    Why is it beneficial for failures to occur early in development rather than late?

    <p>Because it reduces the high cost of failures</p> Signup and view all the answers

    What is a crucial factor in determining the financial viability of investment in a specific biological target?

    <p>The complexity of manufacturing</p> Signup and view all the answers

    What is the primary goal of 'personalized medicine'?

    <p>To identify the right patients for a specific medicine</p> Signup and view all the answers

    What may be necessary when developing a new medicine for a patient population not identified by current diagnostic practices?

    <p>Efforts to enable clinicians to identify the right patients</p> Signup and view all the answers

    What is the main purpose of the discovery phase in the drug discovery and development process?

    <p>To consider multiple molecules to yield a single approved medicine</p> Signup and view all the answers

    What is the outcome of the drug discovery and development process?

    <p>A single approved medicine</p> Signup and view all the answers

    What is a key challenge in developing new medicines for prodromal and preclinical Alzheimer's disease?

    <p>Developing new diagnostic approaches</p> Signup and view all the answers

    More Like This

    Use Quizgecko on...
    Browser
    Browser